protein semaglutide Tepid take: the muscle wasting concern on GLP-1s is probably overblown. 88% of people on aren't hitting targets, averaging 33 grams a day, and yet the muscle loss picture is What I ate in a

Various pharmaceutical and research-focused manufacturers now package peptide formulations under different product systems, including multi-dose pen devices

In musculoskeletal medicine, they address diverse pathological processesincluding inflammation, degeneration, infection, oncology, and fibrosisthrough mechanisms that conventional therapeutics cannot replicate

Increases GLP-1 naturally *based on preclinical studies

Things have changed a lot in the past year

Not a strength comparison

The study was published in March 2024, and found that about 10% of adults in Canada had used a GLP-1 type drug between 900,000 and 1.4 million consumers